Detalles de la búsqueda
1.
A phase Ib study of the highly selective MET-TKI savolitinib plus gefitinib in patients with EGFR-mutated, MET-amplified advanced non-small-cell lung cancer.
Invest New Drugs
; 39(2): 477-487, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33052556
2.
Intracranial effect of osimertinib in relapsed EGFR-mutated T790M-positive and -negative non-small cell lung cancer patients: results from a phase II study.
Acta Oncol
; 60(12): 1565-1571, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34486915
3.
Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study.
Lancet Oncol
; 21(3): 373-386, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32027846
4.
Geographical variations in the use of cancer treatments are associated with survival of lung cancer patients.
Thorax
; 73(6): 530-537, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29511056
5.
Assessing the pattern of recurrence in Danish stage I lung cancer patients in relation to the follow-up program: are we failing to identify patients with cerebral recurrence?
Acta Oncol
; 57(11): 1556-1560, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30010453
6.
The prevalence of ALK rearrangement in pulmonary adenocarcinomas in an unselected Caucasian population from a defined catchment area: impact of smoking.
Histopathology
; 70(6): 889-895, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27943404
7.
The Effect of a Home Delivery Meal Service of Energy- and Protein-Rich Meals on Quality of Life in Malnourished Outpatients Suffering from Lung Cancer: A Randomized Controlled Trial.
Nutr Cancer
; 69(3): 444-453, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28287324
8.
Recruiting newly referred lung cancer patients to a patient navigator intervention (PACO): lessons learnt from a pilot study.
Acta Oncol
; 56(2): 335-341, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28094601
9.
Nintedanib plus docetaxel as second-line therapy in patients with non-small-cell lung cancer of adenocarcinoma histology: a network meta-analysis vs new therapeutic options.
Future Oncol
; 13(13): 1159-1171, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28326832
10.
Prevalence and management of pulmonary comorbidity in patients with lung and head and neck cancer.
Acta Oncol
; 54(5): 767-71, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25907821
11.
Socioeconomic position and survival after lung cancer: Influence of stage, treatment and comorbidity among Danish patients with lung cancer diagnosed in 2004-2010.
Acta Oncol
; 54(5): 797-804, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25761702
12.
Nintedanib plus docetaxel as second-line therapy in patients with non-small-cell lung cancer: a network meta-analysis.
Future Oncol
; 11(3): 409-20, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25478720
13.
The effect of different comorbidities on survival of non-small cells lung cancer patients.
Lung
; 193(2): 291-7, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25516286
14.
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial.
Lancet Oncol
; 15(2): 143-55, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24411639
15.
Survival of patients with small cell lung cancer undergoing lung resection in England, 1998-2009.
Thorax
; 69(3): 269-73, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24172710
16.
High specificity but low sensitivity of mutation-specific antibodies against EGFR mutations in non-small-cell lung cancer.
Mod Pathol
; 27(12): 1590-8, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24762545
17.
A modified exercise protocol may promote continuance of exercise after the intervention in lung cancer patients--a pragmatic uncontrolled trial.
Support Care Cancer
; 21(8): 2247-53, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23508894
18.
Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark.
PLoS One
; 18(4): e0284037, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37040387
19.
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non-Small-Cell Lung Cancer.
J Clin Oncol
; 41(14): 2458-2466, 2023 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37146426
20.
Impact of MET status on treatment outcomes in papillary renal cell carcinoma: A pooled analysis of historical data.
Eur J Cancer
; 170: 158-168, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35640484